 [14] 
Synthesis of cyclobutanone 1:
The cyclobutanone 1 was prepared as a racemic mixture either via method A (as described previously) [1] or, more conveniently, via method B below.
(+/-)-7,7-Dichloro-2-thiabicyclo[3.2.0]hept-3-en-6-one-4-carboxylic acid (1).
Method A:
A mixture of the methoxy acids 2α and 2β (51. 
Method B:
Alternatively, 1 could be prepared in a one-pot three-step procedure from the acid S3 mmol, 3.46 equiv) were dissolved and stirred in dry CCl4 (7 mL) in a 25 mL round-bottom flask under Ar. The reaction mixture was drawn into a 10 mL polypropylene syringe. A syringe filter (Pall GMP acrodisk, 0.45 µm, 2.5 cm dia.) and a stainless steel pipetting needle were attached, and the contents were filtered into an empty 10 mL polypropylene syringe, which was mounted in an inverted position, under gentle flow of Ar through a three-way plastic Luer syringe valve. A 6-inch stainless steel needle was attached to the freshly charged syringe, which was then mounted in an automated syringe pump, with the needle piercing the septum of the flask. The headspace gas was expelled from the syringe, and the addition was started at a rate of 2.5 mL/h (3 h 18 m calculated addition time). Once addition began, the needle was submerged in the reaction medium to prevent the formation of polymeric products at the needle tip. After addition, the reaction was stirred overnight (21 h). 
Racemic mixture of 6,7-di-[ 13 C]-labelled (1S,4S,5S)-and (1R,4R,5R)-7,7-dichloro-6-oxo-

2-thiabicyclo[3.2.0]heptane-4-carboxylic acid ([ 13 C]2-S3)
To a solution of the ester [ 13 C]2-S4 (41.4 mg, 0.053 mmol) in dioxane (2 mL) was added 4 mL of 6 M aq. HCl, and the reaction was stirred at 80 C for 4 h. The reaction mixture was transferred to a separating funnel; water (4 mL) and brine (5 mL) were then added. The mixture was washed with CH2Cl2 (5 × 15 mL), and the combined organic portions were dried (Na2SO4) and concentrated. The crude product, a fine beige solid, contained a small amount of apparent phthalate ester impurity (by 1 H NMR). The material was suspended in hexane (3 mL) and briefly exposed to an ultrasonic bath. After the solids had settled, the hexane was carefully withdrawn and the process was repeated. The remaining solid was dried to give 8.0 mg (62%) of [ The carboxylic acid [ 13 C]2-S3 (8.0 mg, 0.033 mmol) was dissolved in CH2Cl2 (2 mL) in a 25 mL round-bottom flask and SOCl2 (1 mL, 13.7 mmol, 416 equiv.) was added. The mixture was stirred and maintained at 70 C for 4 h. The mixture was concentrated in vacuo, dissolved in CH2Cl2 (2 mL), SO2Cl2 (0.2 mL, 2.47 mmol, 75 equiv.) was added and the reaction was purged with Ar and sealed for overnight stirring at rt. After 20 h, the reaction was concentrated (rotary evaporation at <40 C, and brief exposure to high vacuum at rt), and dissolved in CH2Cl2 (2 mL); MsOH (3 drops) was then added. The reaction was stirred at reflux (60 C bath temp.) for 3 h, cooled to rt, diluted with EtOAc and washed with H2O (7 × 1 mL). The organic phase was dried (Na2SO4) and concentrated to give a mixture (7.8 mg) of the intended product [ 
6,7-Di-[ 13 C]-labelled Ethyl (1S,4S,5S)-and (1R,4R,5R)-7,7-dichloro-6-oxo-
Protein Production and Purification
Recombinant wildtype (wt) SPM-1, Y58C SPM-1 and Y152C SPM-1 proteins were expressed and purified as previously described.
[2] In summary, SPM-1 and variants were expressed in E. coli BL21 (DE3) pLysS grown in 2YT media supplemented with 50 μg/mL ampicillin and 50 μg/mL chloramphenicol. Cells were grown at 37 ºC until OD600 reached ~ 0.6-0.8. After induction with isopropyl-β-D-thiogalactopyranoside (IPTG, 0.5 mM), the temperature was reduced to 30 ºC for 6 h. Cells were harvested and recombinant SPM-1 proteins purified following a 3-step purification protocol as reported.
[2]
F Labeling of SPM-1 Variants and Method Validation
Purified SPM-1 Y58C and SPM-1 Y152C were treated with tris-(2-carboxyethyl)phosphine (TCEP, 2 mM), then incubated on ice (5 min) and buffer exchanged (PD-10 Sephadex G-25 desalting column (GE Healthcare)) into phosphate buffer (50 mM, pH 7.0, 200 mM NaCl). A concentrated stock of 3-bromo-1,1,1-trifluoroacetone (100 mM) in phosphate buffer was freshly prepared prior to the reaction. Samples of SPM-1 variants (0.15 mM) were treated with 3-bromo-1,1,1-trifluoroacetone (2 mM) and incubated for 10 min at room temperature, prior to buffer exchange into Tris buffer (50 mM, pH 7.5, 200 mM NaCl).
The selective incorporation of the label was confirmed by trypsin digestion and MALDI-ToF MS analyses. Circular dichroism and activity assays were followed to confirm that labeling did not affect protein's secondary structure content and activity, respectively. The method validation steps are summarized in Figure S4 as previously reported.
[2a]
NMR Experiments
F NMR experiments
19 F NMR spectra were recorded using a Bruker AVIII 600 MHz NMR spectrometer equipped with a BB-19 F/ 1 H Prodigy N2 cryoprobe using 5 mm diameter NMR tubes (Norell).
Samples contained the 19 F-labeled di-Zn(II)-SPM-1 complex (45 μM) in Tris buffer (50 mM, pH 7.5) supplemented with 10% D2O and 200 mM NaCl, unless otherwise stated.
Cyclobutanone analogue was titrated in the assay mixture from a DMSO stock. Spectra were typically obtained using 512 scans. Trifluoroacetic acid (50 μM) was used as an internal NMR standard. Data were processed using TopSpin 3.1 software (Bruker).
C NMR experiments
NMR experiments were carried out using a Bruker AVIII 700 spectrometer equipped with an inverse TCI cryoprobe optimized for 1 H observation and installed with Topspin 3.1 software (Bruker). The assay mixture contained wt SPM-1 (0.84 mM) and . X-ray data sets were indexed and integrated using XDS [3] or Mosflm, [4] and scaled using Aimless in the CCP4 suite. [5] Structures were solved by molecular replacement using Phaser, [6] using the native SPM-1 structure (PDB ID: 4BP0)
[2b] as a search model, and completed by iterative rounds of manual model building in Coot [7] and refinement in Phoenix. [8] Structure validation was assisted by Molprobity [9] and Phenix. [8] Figures were prepared using PyMOL (www.pymol.org). Coordinates and structure factors have been deposited with the Protein Data Bank (www.rcsb.org/pdb) with accession numbers 5NDE and 5NDB for the unliganded and cyclobutanone-bound structures, respectively.
Figure S1. Outline mechanisms for metallo β-lactamase (MBL) and serine β-lactamase (SBL) catalysis showing proposed intermediates.
[10] Figure S2 . Views from MBL crystal structures highlighting potentially mobile regions. Views of (A) IMP-1 (di-zinc ion B1 MBL, PDB ID: 1JJT) [11] and (B) CphA (monozinc ion B2 MBL, PDB ID: 1X8I)_ENREF_4 [12] highlighting the different mobile regions (L3 loop (red), and α3 region (green)) that characterize the MBL subfamilies. A longer L3 loop (red) is characteristic of the di-Zn B1 MBLs. The B2 MBLs using mono-zinc ion are characterized by an elongated α3 region (green) and a shorter L3 loop (red). Recombinant SPM-1 variants (Y58C and Y152C) were generated by site-directed mutagenesis and produced following a three-step based purification method as reported . LC-MS analyses verified the masses of the recombinant proteins which were in agreement with the calculated masses. The observed mass difference between the unlabeled protein and its labeled counterpart corresponded to the attachment of a single CH2COCF3-label per 19 Flabeled SPM-1 positive ion. The specificity of the labeling method was evaluated by MALDI-ToF-ToF analyses following tryptic digestion. CD analyses and activity monitoring followed to confirm that labeling did not affect the protein secondary structure content and activity, respectively.
[2a] SPM-1* variants were then used to study the binding of 1. [13] and of (B) cyclobutanone 1 binding to SPM-1. The C4 carboxylate of cyclobutanone 1 is positioned to interact with both Zn2 (2.48 Å distance) and Lys219 (2.91 Å), a binding mode likely involved in substrate carboxylate binding in B1 MBLs. [13] The interaction of 1 with Zn2 is proposed to mimic the coordination of the cephalosporin-derived dihydrothiazine ring in the anionic intermediate. [14] and of cyclobutanone 1 binding to SPM-1. Binding of the boronate is proposed to mimic that of bicyclic β-lactams. [14] Structures were superimposed using PyMOL. One oxygen atom of the boronate C-3 carboxylate coordinates to Zn2; the other carboxylate oxygen interacts with Lys224 (NDM-1 and BcII) or Arg228 (via a bridging water molecule in VIM-2) by hydrogenbonding/electrostatic interactions. These interactions are analogous to those with cyclobutanone 1 where the C-4 carboxylate binds Zn2 and Lys219 (similar to hydrolyzed cefuroxime, Figure S7 ). 
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